MANEUVER met all five key secondary endpoints, with statistically significant and clinically meaningful improvements in pain, stiffness, range of motion, physical function, and decrease in tumor volume
The company expects meaningful revenue contribution from this long-term agreement
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
ekincare has raised a total funding of $22M since 2015 till date
The implementation, spearheaded by Deloitte Consulting, brings together domain expertise and cutting-edge technology
DESTINY-Breast09 Phase III trial of AstraZeneca and Daiichi Sankyo’s Enhertu is the first trial in more than a decade to demonstrate superior efficacy across a broad HER2-positive metastatic patient population versus current 1st-line standard of care
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
The plant will have installed production capacity of 3,120 MT/month
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
